Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial - Villa, L L; Costa, R L; Petta, C A (Lancet Oncol, 2005)
et al.